Influence of Varenicline on the Antiplatelet Action of Clopidogrel : the Randomized, Open-label VACL (Varenicline Clopidogrel) Study

Trial Profile

Influence of Varenicline on the Antiplatelet Action of Clopidogrel : the Randomized, Open-label VACL (Varenicline Clopidogrel) Study

Recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Apr 2017

At a glance

  • Drugs Clopidogrel (Primary) ; Varenicline (Primary)
  • Indications Coronary artery disease; Smoking withdrawal; Thromboembolism
  • Focus Pharmacodynamics
  • Acronyms VACL
  • Most Recent Events

    • 23 Jun 2015 Planned End Date changed from 1 Dec 2013 to 1 Apr 2016, according to ClinicalTrials.gov record.
    • 27 Jun 2012 Planned end date changed from 1 Jul 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 09 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top